­
Library Item - Page 52 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Evaluating the effectiveness of longer-term rituximab maintenance therapy in patients with painless non-Hodgkin lymphoma.

Evaluating the effectiveness of longer-term rituximab maintenance therapy in patients with painless non-Hodgkin lymphoma.

Posted by on Aug 29, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study reported the effectiveness and safety of longer rituximab (Rituxan) maintenance therapy schedules (more than 2 years) for the treatment of patients with relapsed or refractory (r/r) indolent (painless) non-Hodgkin lymphoma (iNHL). The data showed that maintenance for up to 2 years with rituximab after response to...

Read More

Comparing TURP and laser prostate surgery for benign prostatic hyperplasia in older patients and those with multiple medical conditions

Comparing TURP and laser prostate surgery for benign prostatic hyperplasia in older patients and those with multiple medical conditions

Posted by on Aug 29, 2021 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study compared the safety and effectiveness of transurethral resection of the prostate (TURP) and laser prostate surgery in older patients and those with multiple medical conditions. The data showed that compared to laser surgery, TURP had a lower risk of needing further surgery but higher complications rates in these...

Read More

Evaluating the effectiveness and safety of ipatasertib plus abiraterone and prednisolone for the treatment of patients with metastatic castration-resistant prostate cancer.

Evaluating the effectiveness and safety of ipatasertib plus abiraterone and prednisolone for the treatment of patients with metastatic castration-resistant prostate cancer.

Posted by on Aug 29, 2021 in Prostate cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety outcomes of ipatasertib (GDC-0068) in combination with abiraterone acetate (Zytiga) plus prednisone (Deltasone) (AAP) for the treatment of patients with previously untreated metastatic castration-resistant prostate cancer (mCRPC). The data showed that ipatasertib plus...

Read More

Evaluating the effectiveness and safety of ciltacabtagene autoleucel for the treatment of patients with unresponsive multiple myeloma.

Evaluating the effectiveness and safety of ciltacabtagene autoleucel for the treatment of patients with unresponsive multiple myeloma.

Posted by on Aug 29, 2021 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the effectiveness and safety of ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR) T-cell therapy for patients with previously treated relapsed or refractory (r/r) multiple myeloma (MM). The data showed that a single dose of cilta-cel was safe and effective for the treatment of these...

Read More

Evaluating eribulin versus other treatment options in women with advanced breast cancer.

Evaluating eribulin versus other treatment options in women with advanced breast cancer.

Posted by on Aug 29, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the safety and effectiveness between eribulin (Halaven) and non-eribulin-based chemotherapy regimens in patients with advanced breast cancer (BC). The data showed that eribulin significantly improved survival outcomes with manageable side effects in these patients. Some background Advanced BC has spread...

Read More

Evaluating the effects of adding chemotherapy to trastuzumab treatment on mental functioning in older patients with HER2-positive breast cancer.

Evaluating the effects of adding chemotherapy to trastuzumab treatment on mental functioning in older patients with HER2-positive breast cancer.

Posted by on Aug 29, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated the effects of adding chemotherapy to trastuzumab (Herceptin) treatment on cognitive (thinking and reasoning) functioning in older patients with HER2-positive (HER2+) breast cancer (BC). The data showed that the addition of chemotherapy did not impact cognitive functioning in these women. Some...

Read More

Can a vegan diet improve diabetes?

Can a vegan diet improve diabetes?

Posted by on Aug 27, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review looked at whether a vegan diet can improve type 2 diabetes (T2D). It found that a vegan diet can lower glucose (sugar) levels for people with T2D. Some background Vegan diets have become more popular, for both health and ethical reasons. A vegan diet includes plant-based foods and avoids meat, eggs, or dairy. But can a vegan...

Read More

Can deep brain stimulation improve stomach problems in patients with Parkinson’s disease?

Can deep brain stimulation improve stomach problems in patients with Parkinson’s disease?

Posted by on Aug 27, 2021 in Parkinson's Disease | 0 comments

In a nutshell This study looked at the effectiveness of deep brain stimulation (DBS) in patients with Parkinson's disease (PD) and stomach problems. It found that DBS was associated with an improvement in stomach disorders and a reduced need for medication. Some background PD is a neurologic condition that can be difficult to treat as...

Read More

Do eye injections reduce the risk of blindness in patients with severe diabetic eye disease?

Do eye injections reduce the risk of blindness in patients with severe diabetic eye disease?

Posted by on Aug 27, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the use of aflibercept (Eylea) eye injections for the treatment of severe nonproliferative diabetic retinopathy (DR; diabetic eye disease). It found that more than half of the patients treated with aflibercept showed a significant improvement in DR after 6 months. Some background DR is one of...

Read More